How Does ELISA Work: Principle, Steps, and Types

ELISA (enzyme-linked immunosorbent assay) works by using antibodies and color-changing enzymes to detect and measure a specific protein or molecule in a sample. The core idea is straightforward: attach your target to a surface, tag it with an enzyme-linked antibody, then add a chemical that changes color when the enzyme acts on it. The more intense the color, the more of the target is present. This simple principle powers everything from HIV screening to pregnancy tests to food safety checks.

The Basic Principle

ELISA exploits one of biology’s most reliable interactions: the lock-and-key fit between an antibody and its target molecule (called an antigen). Antibodies are proteins your immune system makes to recognize specific invaders, and scientists can produce antibodies in the lab that recognize virtually any molecule of interest. In an ELISA, these antibodies are the detection tool.

The test takes place on a small plastic plate, typically containing 96 tiny wells, each about the size of a pencil eraser. The wells are made of polystyrene or similar plastics that proteins naturally stick to. This “stickiness” is what allows the test to work: molecules of interest bind to the plastic surface and stay put through repeated washing steps, while everything else gets rinsed away. By the end of the process, only the target molecule and its detecting antibodies remain in the well, ready to produce a measurable signal.

Step by Step: What Happens in Each Well

Though the exact sequence varies by ELISA type, the most common version (the sandwich ELISA) follows a consistent set of steps. Each step is separated by thorough washing, usually five rinses per cycle, to remove anything that hasn’t specifically bound to its target.

Coating: A “capture” antibody is applied to the well and allowed to stick to the plastic surface. This antibody is chosen because it recognizes one part of the target molecule.

Blocking: A protein solution (often made from milk protein or a similar neutral substance) is added for about an hour to fill any empty spots on the plastic. Without this step, other proteins from the sample could stick nonspecifically to the well and produce misleading results.

Sample addition: The patient’s blood, serum, or other sample is added to the well. If the target molecule is present, it binds to the capture antibody and stays attached through the next wash.

Detection antibody: A second antibody is added, one that recognizes a different part of the same target molecule. This creates a “sandwich” structure: capture antibody on the bottom, target molecule in the middle, detection antibody on top. This incubation typically lasts about two hours at room temperature with gentle shaking.

Enzyme and color reaction: The detection antibody is linked to an enzyme, most commonly horseradish peroxidase (HRP). When a colorless chemical substrate is added, the enzyme converts it into a colored product. The most widely used substrate for HRP produces a blue or yellow color depending on the stage of the reaction. The color deepens over time, and the reaction is stopped at a set point so results are consistent across all wells.

How Color Becomes a Number

After the color develops, a machine called a plate reader shines light through each well and measures how much light gets absorbed. This follows a basic physics principle: the more colored molecules in the solution, the more light they absorb. The reader calculates an absorbance value for each well.

To turn that absorbance into an actual concentration, every ELISA plate includes a set of “standard” wells containing known amounts of the target molecule. These standards form a curve, plotting color intensity against concentration. The plate reader compares each unknown sample’s color to this curve and calculates how much of the target molecule is present. Modern ELISA kits can detect proteins at concentrations in the low picograms-per-milliliter range, which is roughly equivalent to finding a single grain of sugar dissolved in an Olympic swimming pool.

Four Main Types of ELISA

Not every ELISA uses the sandwich approach described above. Four configurations exist, each suited to different situations.

  • Direct ELISA: The target molecule is stuck directly to the plate, and a single enzyme-linked antibody binds to it. This is the simplest and fastest format but also the least sensitive, since there’s only one layer of antibody amplifying the signal.
  • Indirect ELISA: Similar to direct, but uses two antibodies. The first antibody binds the target, and a second enzyme-linked antibody binds the first. This adds sensitivity because multiple enzyme-linked antibodies can pile onto each first antibody.
  • Sandwich ELISA: The most common format for clinical diagnostics. Two antibodies “sandwich” the target as described above. It offers high sensitivity and specificity because two different antibodies must both recognize the target for a signal to appear.
  • Competitive ELISA: Instead of building up signal, this format works in reverse. A known amount of enzyme-labeled target competes with the sample’s target for limited antibody binding sites. More target in the sample means less color, because the labeled version gets outcompeted. This format is useful for detecting small molecules that are too tiny to be sandwiched between two antibodies.

Where ELISA Is Used

ELISA has been a workhorse of medical diagnostics since the 1970s, and its combination of high sensitivity, low cost, and ability to process many samples at once keeps it relevant today.

HIV screening is one of its most well-known applications. Fourth-generation ELISA tests, in use since the mid-2000s, detect both HIV antibodies and a viral protein simultaneously, catching infections earlier than older versions. These screening tests are expected to have at least 99% sensitivity, meaning they miss fewer than 1 in 100 true infections. ELISA has been the standard HIV screening method since 1985, and it remains the preferred first-line test because of its reliability and low cost. Pregnant women are routinely screened with ELISA-based HIV tests to prevent transmission during pregnancy, delivery, and breastfeeding.

Beyond HIV, ELISA is used to measure hormone levels (including the hCG hormone that pregnancy tests detect), diagnose autoimmune diseases, monitor allergies by measuring specific antibody levels, and screen donated blood for infectious agents. In the food industry, ELISA kits detect allergens like peanut protein or gluten in processed foods, and in environmental science, similar kits test water for pesticide contamination.

What Can Go Wrong

ELISA is reliable, but several factors can produce misleading results.

The most counterintuitive problem is the “hook effect,” where an extremely high concentration of the target molecule actually produces a falsely low or negative result. This happens because the target overwhelms both the capture and detection antibodies, saturating them individually so they can’t form the intended sandwich. Each antibody grabs a separate target molecule instead of both grabbing the same one. Labs watch for this by running diluted samples when they suspect very high concentrations.

Cross-reactivity is the most common source of interference, particularly in competitive assays. Molecules that are structurally similar to the target, such as drug metabolites or closely related hormones, can bind to the antibody and inflate or deflate the reading. For example, a cortisol ELISA might partially react to synthetic steroids if the patient is taking them.

Some people carry antibodies in their blood that react with the animal-derived antibodies used in ELISA kits. These “heterophile antibodies” can bridge the capture and detection antibodies on their own, mimicking the target and producing a false positive. Alternatively, they can block the capture antibody, preventing the real target from binding and causing a false negative. This is one reason positive screening results are typically confirmed with a different testing method.

How ELISA Compares to Newer Methods

Chemiluminescent immunoassays (CLIA) are gradually replacing ELISA in high-volume hospital labs. Instead of producing color, CLIA generates light, which can be measured with greater sensitivity and across a wider range of concentrations. A CLIA run takes about 30 minutes from sample to result, compared to 90 to 120 minutes for a standard ELISA. Setup time is also roughly halved: about 20 minutes for 20 samples versus 40 minutes with ELISA.

Still, ELISA holds significant advantages. The equipment is simpler and cheaper, making it accessible in resource-limited settings. The 96-well plate format allows labs to run dozens of samples in parallel with minimal automation. And decades of validation mean ELISA kits exist for an enormous range of targets, many with well-established performance records that newer platforms are still building.